September 24, 2020

The Niche

Knoepfler lab stem cell blog

Month: April 2020

2 min read

Many years ago I started a “not lost in translation” outreach project here on The Niche called SCOPE, meaning Stem Cell Outreach Program for Education. I thought it’d be useful for people all around the world who didn’t necessarily speak English to be able to get authoritative, factual data on stem cells. That was about it. A useful tool. However, it really took off like I never imagined in nearly every country of the world. SCOPE has a stem cell white paper in 34 …Read More

3 min read

  It’s been a busy week for the cellular and regenerative medicine space for COVID-19 news with some possible ups including for Mesoblast and some definite downs. Starting with the more positive media buzz with have Mesoblast. Mesoblast made COVID19 news “Thinly traded Mesoblast Limited (NASDAQ:MESO) rockets 51% premarket on average volume in reaction to its announcement of an 83% (n=10/12) survival rate in ventilator-dependent COVID19 patients who were treated with its allogeneic mesenchymal stem cell product candidate remestemcel-L within the first five days. Nine of the 10 …Read More

3 min read

A firm called Kimera labs just received an untitled letter from the FDA. The firm has been supplying non-FDA-approved exosomes to various customers including at least one stem cell clinic without sparking any obvious action from the agency, but on April 10th that changed with the letter, which in my view is quite serious. What sparked it? My sense is that a major trigger was Kimera Labs being linked some weeks back to an experimental infusion of exosomes into a COVID19 patient. The letter …Read More

2 min read

The California Stem Cell Agency, better known by the acronym CIRM, has done a vast amount of good over the past decade and a half, and today it needs your help for the future. CIRM, which stands for the “California Institute for Regenerative Medicine”, has funded a huge array of stem cell and other research projects. The CIRM of today and the future primarily supports clinical trial efforts aimed at finding new treatments and even cures for many serious illnesses. These efforts now even …Read More